Use: With an annual incidence of 10-12 cases per 100 000, aneurysmal subarachnoid
hemorrhage is a major cause of death or disability. 1 Over 30% of patients die within 24 …

The birth of Guglielmi detachable coils (GDCs) a decade ago [1, 2] has injected new life into
the treatment of cerebral aneurysms, gradually changing the management of subarachnoid …

OBJECTIVE: The purpose of this report is to provide the most detailed treatment and
outcome data currently available in the literature, to allow for the further evaluation of …

Object. The aim of this study was to assess the incidence and outcome of procedure-related
rupture of intracranial aneurysms in patients treated with Guglielmi detachable coils (GDCs) …

Background No randomized trial of intracranial aneurysm coiling has compared long-term
efficacy of polymer-modified coils to bare metal coils (BMCs). We report 5-year results …

PURPOSE: To evaluate the stability of aneurysm occlusion over time, the need for additional
treatments, and the long-term clinical outcome of patients, with emphasis on late …

We read the article by Debrun et al.(2) with interest. They reported on a retrospective
analysis of 329 patients with 339 aneurysms who were treated at the University of Illinois …

Since the introduction of the Gugliemli detachable coils (GDCs) in clinical research trials in
1991, over 40,000 patients worldwide with cerebral aneurysms have been treated with the …

OBJECTIVE A prospective multicenter registry was conducted in France to evaluate the
safety and efficacy of Matrix coils (Boston Scientific Neurovascular, Fremont, CA). The short …

BACKGROUND AND PURPOSE: The long-term durability of Guglielmi detachable coil
(GDC) embolization of cerebral aneurysms is still unknown. The purpose of this study was to …